Neuphoria Therapeutics Inc.
NEUP
Rang in Aktien
#29141
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Aktienkurs
$3.92
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$21.16M
Veränderung (1 Tag)
-0.13%
Veränderung (1 Jahr)
60,767.52%
Land
US
Handel Neuphoria Therapeutics Inc. (NEUP)
Kategorie
Healthcare
Kursverlauf für Neuphoria Therapeutics Inc. (NEUP)
Höchster Schlusskurs: $0.01 am 2023-08-01
Niedrigster Schlusskurs: $0.56 am 1999-12-01
Niedrigster Schlusskurs: $0.56 am 1999-12-01
Kursverlauf der Aktie von Neuphoria Therapeutics Inc. von 1999 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.79 | -3.81% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
